AAAAAA
Results:
1-8
|
Results: 8
Authors:
Vaccaro, O
Perna, AF
Mancini, FP
Iovine, C
Cuomo, V
Sacco, M
Tufano, A
Rivellese, AA
Ingrosso, D
Riccardi, G
Citation: O. Vaccaro et al., Plasma homocysteine and microvascular complications in type 1 diabetes, NUTR MET CA, 10(6), 2000, pp. 297-304
Authors:
Vaccaro, O
Citation: O. Vaccaro, Risk factors for the development of diabetes, NUTR MET CA, 10(5), 2000, pp. 237-238
Authors:
Vaccaro, O
Mancini, FP
Ruffa, G
Sabatino, L
Colantuoni, V
Riccardi, G
Citation: O. Vaccaro et al., Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) and severe obesity: a case-control study, INT J OBES, 24(9), 2000, pp. 1195-1199
Authors:
Vaccaro, O
Perna, AF
Mancini, FP
Cuomo, V
Sacco, M
Tufano, A
Rivellese, AA
Ingrosso, D
Riccardi, G
Citation: O. Vaccaro et al., Plasma homocysteine and its determinants in diabetic retinopathy, DIABET CARE, 23(7), 2000, pp. 1026-1027
Authors:
Vaccaro, O
Ruffa, G
Riccardi, G
Citation: O. Vaccaro et al., Is there any use for the oral glucose tolerance test?, DIABET CARE, 23(5), 2000, pp. 714-715
Authors:
Pasanisi, E
Imperatore, G
Vaccaro, O
Iovine, C
Ferrara, LA
Citation: E. Pasanisi et al., Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension, NUTR MET CA, 9(2), 1999, pp. 73-77
Risk of diabetes in the new diagnostic category of impaired fasting glucose - A prospective analysis
Authors:
Vaccaro, O
Ruffa, G
Imperatore, G
Iovino, V
Rivellese, AA
Riccardi, G
Citation: O. Vaccaro et al., Risk of diabetes in the new diagnostic category of impaired fasting glucose - A prospective analysis, DIABET CARE, 22(9), 1999, pp. 1490-1493
Authors:
Mancini, FP
Vaccaro, O
Sabatino, L
Tufano, A
Rivellese, AA
Riccardi, G
Colantuoni, V
Citation: Fp. Mancini et al., Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma 2 is not associated with type 2 diabetes, DIABETES, 48(7), 1999, pp. 1466-1468
Risultati:
1-8
|